+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Medical Footwear Market Size, Share & Trends Analysis Report by End Use (Men, Women), by Distribution Channel (Offline, Online), by Region (North America, Europe, APAC, Central & South America, MEA), and Segment Forecasts, 2020-2027

  • PDF Icon

    Report

  • 80 Pages
  • August 2020
  • Region: Global
  • Grand View Research
  • ID: 5144653
Medical Footwear Market Growth & Trends

The global medical footwear market size is anticipated to reach USD 12.97 billion by 2027, expanding at a CAGR of 5.7% over the forecast period. Increasing cases of foot-related issues, ankle sprain, ulcers, diabetes, and strain and foot pain owing to obesity are expected to fuel the growth of this market. According to the American Podiatric Medical Association (APMA), in 2018, close to 81% of obese people accepted that they have witnessed foot pain and multiple foot and ankle conditions due to overweight.

The men segment led the market and accounted for 57.2% share of the global revenue in 2019. Increasing technological innovation and product launches have been driving the demand for medical footwear. For instance, in 2019, Footwear Unlimited, Inc. brand Baretraps introduced comfortable shoes with Posture+ technology that help the wearer to correct the posture and reduce strain and pressure on knees, toes, and ankle. The shoes come with a supportive heel cup and a built-in orthotic that reduces the foot pain.

The women segment is expected to register the fastest CAGR of 5.9% from 2020 to 2027. Manufacturers have been broadening their product portfolio by launching casual looking shoes for women, which is proliferating the segment growth. For instance, in July 2019, Dr. Comfort, a medical footwear brand, launched an athleisure-style shoe, The Ruth in women’s category, made of full-grain leather and has reduced seam lines, protective toe box, stable outsoles, removable outsoles, and anti-abrasion material to aid durability, stability, and support.

The COVID-19 (coronavirus) outbreak has severely impacted the footwear industry, including medical footwear, with a reduction in demand owing to store closures, lockdown measures, and restriction in imports and exports at the global level. Sales data reported for Amazon between mid-February and mid-March 2020 showed footwear sales fell by an average of 40 percentage points. Consumers have become more conscious of their spending habits and tend to purchase mostly essential products, which is a major challenge for the market.

The online distribution channel is expected to witness the fastest growth over the forecast period. The rising popularity of e-commerce channels among the manufacturers and high internet penetration among millennials, Gen Z, and Gen X have been driving the sale through this channel. E-commerce websites such as Amazon, Flipkart, Orthorest, and Dr. Comfort offer discounts, deals, and new launches, which attract the consumers and fuel the segment growth.

North America dominated the market for medical footwear and accounted for 33.5% share of the global revenue in 2019. The growth of the regional market is powered by an increasing number of people witnessing foot-related issues in the region. According to a report by the American Podiatric Medical Association, 50% of Americans have limited their outdoor activities due to foot pain because of poor design shoes and high impact activities, such as jumping, running, and dancing.

Asia Pacific is expected to register the fastest CAGR of 6.1% from 2020 to 2027. Increasing cases of diabetes in the region are expected to drive the demand for medical footwear. Moreover, people in the countries, including China, India, and Japan, have become more conscious of their health and are willingly purchasing footwear that can offer relief to chronic foot pain.

Medical Footwear Market Report Highlights
  • The online distribution channel emerged as the fastest distribution channel in 2019 and is expected to maintain its lead throughout the forecast period. The increasing availability of medical footwear of different brands, free delivery, and seasonal discount on e-retailer platforms are among the major reasons fueling the segment growth.
  • The men segment led the market and accounted for 57.2% share of the global revenue in 2019.
  • Asia Pacific is the fastest growing regional market with a CAGR of 6.1% from 2020 to 2027. Growing awareness among people regarding the benefits of medical footwear including increased blood flow, improved mobility, and enhanced foot support is expected to drive the regional market.

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.2. Market Definition
1.3. Information Procurement
1.3.1. Purchased Database
1.3.2. Internal Database
1.3.3. Secondary Sources & Third-Party Perspectives
1.3.4. Primary Research
1.4. Information Analysis
1.4.1. Data Analysis Models
1.5. Market Formulation & Data Visualization
1.6. Data Validation & Publishing
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segmental Outlook
2.3. Competitive Insights
Chapter 3. Medical Footwear Market Variables, Trends & Scope
3.1. Market Introduction
3.2. Penetration & Growth Prospect Mapping
3.3. Industry Value Chain Analysis
3.3.1. Sales/Retail Channel Analysis
3.3.2. Profit Margin Analysis
3.4. Market Dynamics
3.4.1. Market Driver Analysis
3.4.2. Market Restraint Analysis
3.4.3. Industry Challenges
3.4.4. Industry Opportunities
3.5. Business Environment Analysis
3.5.1. Industry Analysis-Porter’s
3.5.1.1. Supplier Power
3.5.1.2. Buyer Power
3.5.1.3. Substitution Threat
3.5.1.4. Threat from New Entrant
3.5.1.5. Competitive Rivalry
3.6. Roadmap of Medical Footwear Market
3.7. Market Entry Strategies
3.8. Impact of COVID-19 Pandemic on Medical Footwear Market
Chapter 4. Consumer Behavior Analysis
4.1. Consumer Trends and Preferences
4.2. Factors Affecting Buying Decision
4.3. Consumer End use Adoption
4.4. Observations & Recommendations
Chapter 5. Medical Footwear Market: End Use Estimates & Trend Analysis
5.1. End use Analysis & Market Share, 2019 & 2027
5.2. Men
5.2.1. Market estimates and forecast, 2016-2027 (USD Million)
5.3. Women
5.3.1. Market estimates and forecast, 2016-2027 (USD Million)
Chapter 6. Medical Footwear Market: Distribution Channel Estimates & Trend Analysis
6.1. Distribution Channel Analysis & Market Share, 2019 & 2027
6.2. Offline
6.2.1. Market estimates and forecast, 2016-2027 (USD Million)
6.3. Online
6.3.1. Market estimates and forecast, 2016-2027 (USD Million)
Chapter 7. Medical Footwear Market: Regional Estimates & Trend Analysis
7.1. Regional Movement Analysis & Market Share, 2019 & 2027
7.2. North America
7.2.1. Market estimates and forecast, 2016-2027 (USD Million)
7.2.2. Market estimates and forecast, by end use, 2016-2027 (USD Million)
7.2.3. Market estimates and forecast, by distribution channel, 2016-2027 (USD Million)
7.2.4. The U.S.
7.2.4.1. Market estimates and forecast, 2016-2027 (USD Million)
7.2.4.2. Market estimates and forecast, by end use, 2016-2027 (USD Million)
7.2.4.3. Market estimates and forecast, by distribution Channel, 2016-2027 (USD Million)
7.3. Europe
7.3.1. Market estimates and forecast, 2016-2027 (USD Million)
7.3.2. Market estimates and forecast, by end use, 2016-2027 (USD Million)
7.3.3. Market estimates and forecast, by distribution channel, 2016-2027 (USD Million)
7.3.4. Germany
7.3.4.1. Market estimates and forecast, 2016-2027 (USD Million)
7.3.4.2. Market estimates and forecast, by end use, 2016-2027 (USD Million)
7.3.4.3. Market estimates and forecast, by distribution channel, 2016-2027 (USD Million)
7.3.5. The U.K.
7.3.5.1. Market estimates and forecast, 2016-2027 (USD Million)
7.3.5.2. Market estimates and forecast, by end use, 2016-2027 (USD Million)
7.3.5.3. Market estimates and forecast, by distribution channel, 2016-2027 (USD Million)
7.3.6. France
7.3.6.1. Market estimates and forecast, 2016-2027 (USD Million)
7.3.6.2. Market estimates and forecast, by end use, 2016-2027 (USD Million)
7.3.6.3. Market estimates and forecast, by distribution channel, 2016-2027 (USD Million)
7.4. Asia Pacific
7.4.1. Market estimates and forecast, 2016-2027 (USD Million)
7.4.2. Market estimates and forecast, by end use, 2016-2027 (USD Million)
7.4.3. Market estimates and forecast, by distribution channel, 2016-2027 (USD Million)
7.4.4. China
7.4.4.1. Market estimates and forecast, 2016-2027 (USD Million)
7.4.4.2. Market estimates and forecast, by end use, 2016-2027 (USD Million)
7.4.4.3. Market estimates and forecast, by distribution channel, 2016-2027 (USD Million)
7.4.5. India
7.4.5.1. Market estimates and forecast, 2016-2027 (USD Million)
7.4.5.2. Market estimates and forecast, by end use, 2016-2027 (USD Million)
7.4.5.3. Market estimates and forecast, by distribution channel, 2016-2027 (USD Million)
7.5. Central & South America
7.5.1. Market estimates and forecast, 2016-2027 (USD Million)
7.5.2. Market estimates and forecast, by end use, 2016-2027 (USD Million)
7.5.3. Market estimates and forecast, by distribution channel, 2016-2027 (USD Million)
7.5.4. Brazil
7.5.4.1. Market estimates and forecast, 2016-2027 (USD Million)
7.5.4.2. Market estimates and forecast, by end use, 2016-2027 (USD Million)
7.5.4.3. Market estimates and forecast, by distribution channel, 2016-2027 (USD Million)
7.6. Middle East & Africa (MEA)
7.6.1. Market estimates and forecast, 2016-2027 (USD Million)
7.6.2. Market estimates and forecast, by end use, 2016-2027 (USD Million)
7.6.3. Market estimates and forecast, by distribution channel, 2016-2027 (USD Million)
Chapter 8. Competitive Analysis
8.1. Key global players, recent developments & their impact on the industry
8.2. Key Company/Competition Categorization (Key innovators, Market leaders, Emerging players)
8.3. Vendor Landscape
8.3.1. Key company market share analysis, 2019
Chapter 9. Company Profiles
9.1. Dr. Comfort
9.1.1. Company Overview
9.1.2. Financial Performance
9.1.3. End use Benchmarking
9.1.4. Strategic Initiatives
9.2. New Balance
9.2.1. Company Overview
9.2.2. Financial Performance
9.2.3. End use Benchmarking
9.2.4. Strategic Initiatives
9.3. Dr. Zen Inc.
9.3.1. Company Overview
9.3.2. Financial Performance
9.3.3. End-use Benchmarking
9.3.4. Strategic Initiatives
9.4. Gravity Defyer Corp
9.4.1. Company Overview
9.4.2. Financial Performance
9.4.3. End-use Benchmarking
9.4.4. Strategic Initiatives
9.5. Dr. Foot Inc.
9.5.1. Company Overview
9.5.2. Financial Performance
9.5.3. End-use Benchmarking
9.5.4. Strategic Initiatives
9.6. OrthoFeet
9.6.1. Company Overview
9.6.2. Financial Performance
9.6.3. End-use Benchmarking
9.6.4. Strategic Initiatives
9.7. Duna
9.7.1. Company Overview
9.7.2. Financial Performance
9.7.3. End-use Benchmarking
9.7.4. Strategic Initiatives
9.8. Mephisto
9.8.1. Company Overview
9.8.2. Financial Performance
9.8.3. End-use Benchmarking
9.8.4. Strategic Initiatives
9.9. Aetrex Worldwide, Inc.
9.9.1. Company Overview
9.9.2. Financial Performance
9.9.3. End-use Benchmarking
9.9.4. Strategic Initiatives
9.10. DARCO International, Inc.
9.10.1. Company Overview
9.10.2. Financial Performance
9.10.3. End-use Benchmarking
9.10.4. Strategic Initiatives

Companies Mentioned

  • Dr. Comfort
  • New Balance
  • Dr. Zen Inc.
  • Gravity Defyer Corp
  • Dr. Foot Inc.
  • OrthoFeet
  • Duna
  • Mephisto
  • Aetrex Worldwide, Inc.
  • DARCO International, Inc.

Methodology

Loading
LOADING...